Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:55 2025-12-16 am EST			5-day change	1st Jan Change
62.48 ^CHF	-1.20%		-2.62%	-18.75%

08:20am	ISS Advises Staar Surgical Shareholders to Vote for Alcon Takeover Bid in Updated Recommendation	MT
06:30am	STAAR Surgical Shareholders Urged to Vote in Favor of Merger With Alcon	MT

Alcon, Inc. acquired ClarVista Medical, Inc. from New Enterprise Associates for approximately $130 million.

Published on 11/12/2018

S&P Capital IQ

Alcon Inc.

-1.20%

Alcon, Inc. (SWX:ALC) acquired ClarVista Medical, Inc. from New Enterprise Associates for approximately $130 million on December 15, 2017. The consideration consists of $71 million in cash and $54 million as contingent consideration due to ClarVista shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. Alcon, Inc. (SWX:ALC) completed the acquisition of ClarVista Medical, Inc. from New Enterprise Associates on December 15, 2017.

Latest news about Alcon Inc.

08:20am	ISS Advises Staar Surgical Shareholders to Vote for Alcon Takeover Bid in Updated Recommendation	MT
06:30am	STAAR Surgical Shareholders Urged to Vote in Favor of Merger With Alcon	MT
Dec. 12	Glass Lewis Reaffirms its Recommendations to Shareholders of STAAR	CI
Dec. 11	Stocks Extend Losing Streak as Swiss National Bank Holds Key Rate at Zero	MT
Dec. 11	STAAR Surgical Says No 'Credible Buyer' During Go-Shop Process in Alcon Deal	MT
Dec. 11	STAAR Surgical Investor Broadwood Partners Says Alcon's Proposed Acquisition Remains 'Unfair' to Shareholders	MT
Dec. 11	Broadwood Partners comments on STAAR Surgical board dissent on revised sale to Alcon	RE
Dec. 10	Yunqi Capital Comments on STAAR Surgical?s Go-Shop Process	CI
Dec. 10	Sector Update: Health Care Stocks Rise Premarket Wednesday	MT
Dec. 10	STAAR Surgical Acquisition by Alcon Opposed by Investor Yunqi Capital	MT
Dec. 10	Yunqi Capital comments on Staar Surgical's go-shop process and Alcon's revised offer	RE
Dec. 10	Swiss stocks - Factors to watch on December 10	RE
Dec. 09	Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical	DJ
Dec. 09	Broadwood Partners continues to urge Staarr shareholders to vote "against" proposed transaction with Alcon	RE
Dec. 09	Swiss Market Index Retreats; Swiss Re Shares Down	MT
Dec. 09	Staar Surgical Shares Surge as Alcon Boosts its Buyout Price	DJ
Dec. 09	Alcon Ups Takeover Bid for Staar Surgical Under Amended Merger Deal	MT
Dec. 09	Alcon Upgrades Offer Price for Staar Surgical	DJ
Dec. 09	Swiss eyecare giant Alcon lifts bid for rival Staar	RE
Dec. 09	Alcon Increases Bid to Acquire STAAR Surgical to $1.6 Billion	MT
Dec. 09	Alcon lifts offer for Staar Surgical merger to $1.6 billion	RE
Dec. 08	Sector Update: Health Care Stocks Fall Late Afternoon	MT
Dec. 08	STAAR Surgical Shareholder Broadwood Partners Reiterates Opposition to Alcon Transaction	MT
Dec. 08	STAAR Surgical Announces Expiration of Go-Shop Period	CI
Dec. 08	Sector Update: Health Care Stocks Lower in Afternoon Trading	MT

Chart Alcon Inc.

Duration

Period

ALC: Dynamic Chart

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.1%): consumables (51.8% of net sales), implantable products (32.1%) and other products (16.1%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.9%): contact lenses (60.5% of sales) and eye care products (39.5%; eye drops and ophthalmic ointments, etc.). At the end of 2024, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.8%), the United States (45.9%), China (5.7%), Japan (5.6%) and other (42%).

Employees

25,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

Jan. 13 - J.P. Morgan Healthcare Conference

More about the company